Warfarin, calciphylaxis, atrial fibrillation, and patients on dialysis: Outlier subsets and practice guidelines

American Journal of Medicine

Volumn 127, Issue 4, 2014, Pages 253-254

  Eiser, Arnold R ^a,b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Mercy Health System Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOCALCIN; VITAMIN D; VITAMIN K GROUP; WARFARIN;

ANTICOAGULATION; BLEEDING TENDENCY; BRAIN HEMORRHAGE; CALCINOSIS; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; CLINICAL DECISION MAKING; CLINICAL TRIAL (TOPIC); DIALYSIS; END STAGE RENAL DISEASE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERPHOSPHATEMIA; NOTE; OSTEOBLAST; OSTEOCLAST; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCORING SYSTEM; VASCULAR SMOOTH MUSCLE;

ANTICOAGULANTS; ATRIAL FIBRILLATION; CALCIPHYLAXIS; HUMANS; KIDNEY FAILURE, CHRONIC; PRACTICE GUIDELINES AS TOPIC; RENAL DIALYSIS; STROKE; WARFARIN;

EID: 84897070369     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2013.08.033     Document Type: Editorial

References (12)

1. V.M. Brandenberg, R. Kramann, P. Specht, and M. Ketteler Calciphylaxis in CKD and beyond Nephrol Dial Transplant 27 2012 1314 1318
2. S.U. Nigwekar, I. Bhan, and A. Turchin et al. Statin use and calcific uremic arteriolopathy: a matched case-control study Am J Nephrol 37 2013 325 332
3. F. Yang, D. Chou, P. Schweitzer, and S. Hanon Warfarin in haemodialysis patients with atrial fibrillation: what benefit? Europace 12 2010 1666 1672
4. S.R. Presnell, and D.W. Stafford The vitamin K-dependent carboxylase Thromb Haemost 87 2002 937 946
5. Health Policy Briefs: Pay for Performance. Health Affairs. Available at: http://www.healthaffairs.org/healthpolicybriefs/brief.php?brief-id=78. Accessed July 31, 2013.
6. J.J. You, D.E. Singer, and P.A. Howard et al. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 2 Suppl 2012 e531S e575S
7. G. Karthikeyan, and J.W. Eikelboom The CHADS2 score for stroke risk stratification in atrial fibrillation-friend or foe? Thromb Haemost 104 2010 45 48
8. G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation Chest 137 2010 263 272
9. K.E. Chan, J.M. Lazarus, R. Thadhani, and R.M. Hakim Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation J Am Soc Nephrol 20 2009 2223 2333
10. M. Wiesholzer, F. Harm, G. Tomasec, G. Barbieri, D. Put, and P. Balcke Incidence of stroke among chronic hemodialysis patients with non-rheumatic atrial fibrillation Am J Nephrol 21 2001 35 39
11. W.M. Bennett Should dialysis patients ever receive warfarin and for what reasons? Clin J Am Soc Nephrol 1 2006 1357 1359
12. G. Lai, A.G. Nowell, J. Liao, S.L. Sugg, R.J. Weigel, and J.R. Howe Determinants of survival in patients with calciphylaxis: a multivariate analysis Surgery 146 2009 1028 1034